Investing.com -- Mizuho analysts have downgraded Chewy (NYSE: CHWY) to Neutral, removing its "Top Pick" status, stating that ...

Inc to Neutral from Buy given a weaker-than-expected market share gains, rising competition in advanced driver assistance ...

Capital Markets’ Chief Investment Strategist Brian Belski said that the recent uncertainty tied to tariffs has led to ...

Jefferies analysts maintained a Buy rating on Oracle (NYSE:ORCL) in a note Monday, raising their price target for the stock to $200 from $190 a share.  The firm told investors that it is seeing "more ...

Newsom, a Democrat, requested the Trump administration to withdraw the order to deploy 2,000 National Guard troops, stating ...

Despite short-term concerns such as lower trading volumes, margin balances, and potential Federal Reserve rate cuts, Redburn sees Interactive Brokers as underappreciated. Its earnings estimates for ...

Investing.com -- KULR Technology Group Inc (NYSE American:KULR) shares climbed 2% following the announcement that the company has joined the " Bitcoin for Corporations" initiative, signaling a ...

Citius Pharmaceuticals Inc (NASDAQ: CTXR ), the parent company of Citius Oncology, also saw its shares climb by 6.7%. Meanwhile, Cardinal Health’s stock remained flat after the news.

Morgan Stanley analysts raised their price target for AppLovin (NASDAQ:APP) to $460 from $420 a share in a note Monday, ...

Investing.com -- Morgan Stanley downgraded Lululemon Athletica (NASDAQ: LULU) to Equal-weight from Overweight and cut its price target to $280 on waning confidence in a recovery in the company’s core ...

In a recent report, NATO estimated Canadian defense spending at 1.45% of GDP for 2024, still well below the alliance’s ...

Metsera’s proprietary HALO™ platform technology underpins the development of MET-233i, which aims to offer patients a more convenient dosing schedule with substantial weight loss. The positive trial ...